Guangzhou Jet Bio-Filtration Co., Ltd.
688026.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.85B
Close$
$5.36
78.9% downside
Current Fair Value
78.9% downsideOvervalued by 78.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.85 Billion |
|---|---|
| Enterprise Value | $3.94 Billion |
| Dividend Yield | $0.07 (0.26%) |
| Earnings per Share | $0.35 |
| Beta | 0.55 |
| Outstanding Shares | 136,117,625 |
Return
| Return on Equity | 1.90% |
|---|---|
| Return on Assets | 1.31% |
| Return on Invested Capital | 0.92% |
Valuation & Multiples
| P/E Ratio | 171.89 |
|---|---|
| PEG | -1061.83 |
| Price to Sales | 6.35 |
| Price to Book Ratio | 3.17 |
| Enterprise Value to Revenue | 6.85 |
| Enterprise Value to EBIT | 262.52 |
| Enterprise Value to Net Income | 173 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.34 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 31, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$174.00 M
Average shareholder expectationNext Earnings Call
Expected Date
October 31, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$169.60 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Guangzhou Jet Bio-Filtration Co., Ltd.
1,490 employees
CEO: Jianhua Yuan Guangzhou Jet Bio-Filtration Co., Ltd. specializes in the research, development, manufacturing, and global distribution of a diverse range of laboratory products. Their extensive catalog features essential lab consumables like pipettes, ...